Gross Margin

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

The water midstream leader's inaugural dividend signals financial confidence, but a look at its balance sheet reveals a complex picture of growth and debt.

With a booming subscription business and a focus on AI, Arlo Technologies is set to outline its future vision for the competitive smart home security market.

The enterprise AI firm announced major layoffs after missing revenue targets, but points to strong government contract growth as a path to profitability.

Fintech giant Chime forecasts its first full year of GAAP profitability in 2026, propelled by its new ChimeCore platform, AI, and strong product growth.

With record revenue and key battery tech milestones met, Enovix is on the brink of powering smartphones, but manufacturing hurdles and cash burn remain.

The homebuilder met goals despite a tough market and is looking to new US communities and a major expansion in Saudi Arabia for future profits.

With record growth and new security tools, Addigy is redefining Apple device management, challenging rivals and setting a new standard for IT teams.

XPEL reports a massive 50% jump in Q4 net income, yet shares tumble as a revenue miss and a cautious 2026 outlook overshadow the impressive profit growth.

The spirits giant faces a steep sales decline and a massive write-down, pivoting to premium brands and operational fixes amid an industry-wide hangover.

Intellicheck's new desktop tool promises immediate, advanced identity verification without complex integration, leveling the security field for businesses.

Legal tech firm DISCO reports strong growth fueled by a 600% surge in AI revenue, launching agentic AI and a disruptive new all-in-one pricing model.

While many cannabis firms struggle, Greenway Greenhouse reports a 40% revenue jump, expanding margins, and its fifth straight quarter of positive EBITDA.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

Vow ASA reports record Q4 revenues but shifts strategy to focus on its booming maritime sector, following major write-downs in its industrial division.

The diabetes tech firm secures major funding for innovation and acquisitions, using a savvy financial strategy to protect current shareholder value.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Heritage Insurance projects a stunning full-year return on equity over 45%, setting the stage for a blockbuster earnings report on March 9.